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Abstract 
The expression of Annexins V and VIII by human lung, liver, kidney, skin, heart, uterus, spleen and skeletal muscle was investigated by ELISA. 
All investigated tissues contained Annexin V. Its level varied with the tissue from around 5 pg (skin) to approximately 120 pg (spleen) per g of wet 
tissue. Contradistinctionally Annexin VIII expression was less ubiquitous and less abundant. Only lung, skin, liver and kidney expressed Annexin 
VIII. Its levels were approximately lOO-fold less then the Annexin V levels. Immunohistochemical analysis of lung sections revealed Annexin VIII 
presence exclusively in the endothelia. Annexin V and VIII levels of cultured human umbilical vein endothelial cells, human arterial smooth muscle 
cells, human lung fibroblasts and HeLa cells were measured by ELISA. All cell types expressed Annexin V whereas only HeLa cells had detectable 
levels of Annexin VIII. The results indicate a tissue specific expression of Annexin VIII by lung endothelium, suggesting a highly specialised function. 
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1. Introduction 
Annexins constitute a multigene family of proteins de- 
fined by a repeated sequence motif initially termed the 
endonexin loop [l]. Proteins containing this motif have 
been identified in animals from widely separated phyla 
such as Poriphera [2], Cnidaria [3], Arthropoda [4] and 
Chordata [5-131. Within the subphylum of vertebrates a 
high structural conservation of individual Annexins ap- 
pears between different species. Evolution of the family 
is hypothesised to have occurred by duplication events 
of a progenitor gene containing the code for this motif 
[14]. The sequence motif is directly related to the func- 
tional properties of calcium and phospholipid binding 
[15,16]. Diversification of the family into at least 10 dif- 
ferent Annexins in animals has probably emerged from 
the physiological need to diverse on the central theme of 
calcium and phospholipid binding. The physiological 
significance of the family as a whole and of the individual 
members in particular, however, are still not fully under- 
stood in spite of the wealth of available data (for reviews 
see [17-191). 
Up to now Annexin VIII is amongst the least de- 
scribed members of the family. It was initially discovered 
as a gene product by a screening procedure of a human 
cDNA library with a probe specific for Annexin V [l I]. 
Recombinant Annexin VIII appeared to exhibit the An- 
nexin typical biological properties like Ca”-dependent 
phospholipid binding and inhibition of phospholipase A, 
and prothrombinase activity [ll]. Recently the native 
protein was purified from human placenta [20] where it 
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accounts for less than 1% of the Annexins. In this respect 
Annexin VIII appears less abundant and less ubiquitous 
as other Annexins, which points to a specialised func- 
tion. Recently Annexin VIII gene activation was re- 
ported in various leukemic and lymphoid cells [2 1,221. It 
was hypothesized that Annexin VIII plays a unique role 
in the proliferation and/or differentiation of these cells 
[211. 
This paper reports on an investigation of the expres- 
sion of Annexin VIII protein by various human tissues 
and its localisation as determined by ELISA and immu- 
nohistochemistry, respectively, using polyclonal anti- 
bodies that were raised against recombinant Annexin 
VIII. 
2. Materials and methods 
2.1. Proteins 
Recombinant Annexin V and VIII were obtained from Escherichia 
coli transformed with pRH291 and pRH292, respectively, as described 
elsewhere [I 1,231. Monoclonal and polyclonal antibodies against re- 
combinant Annexin V were produced as described elsewhere [24]. 
2.2. Cell cultures 
Human umbilical vein endothelial cells (HUVEC) were isolated from 
veins of freshly obtained human umbilical cords and cultured according 
to Jaffe et al. [25] on fibronectin (a kind gift of Dr. J. van Mourik, 
Amsterdam) coated tissue culture flasks in culture medium (RPM1 
1640; Flow Lab.), supplemented with 20% newborn calf serum (NCS; 
Gibco), heparin (50 ,ug/ml; Sigma H.8514), bovine brain Endothehal 
Cell Growth Factor Supplement (20 ,@/ml; Boehringer Mannheim), 
L-glutamine (2 mM; Flow Lab.), streptomycin (100 pglml) and penicil- 
lin (100 IU/ml). Arterial smooth muscle cells (SMC) were derived from 
tissue explants of human umbilical cord arteries as described by Ross 
[26]. The SMC were further cultured on fibronectin coated tissue cul- 
ture flasks in culture medium without heparin and ECGF. Human 
embryonic lung fibroblasts (Cell line Flow 2002) and HeLa cells (cell 
line ATCC CCL2) were cultured on uncoated tissue culture flasks in 
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Eagle’s MEM, supplemented with 1% non-essential amino acids, 10% 
NCS, L-glutamine (2 mM), streptomycin (100 fig/ml) and penicillin 
(100 W/ml). 
2.3. Annexin VIII antibody preparation 
Polyclonal antibodies against recombinant Annexin VIII were raised 
in rabbits using standard procedures. The IgG fraction of the antiserum 
was enriched by (NH,),SO, precipitation. Immunoaffinity purified 
antibodies (IA-Abv,,,) were obtained by chromatography of the IgG 
fraction using a column of Annexin VIII, that was immobilized on 
Affigel- 15 (BioRad). IA-Abv,,, were conjugated with NHS-LC-biotin 
(Pierce) according to the instructions of the supplier. 
2.4. Annexin V and VIII specific ELISA 
The Annexin V specific ELISA is based on a polyclonal antibody as 
a catching antibody and a monoclonal antibody as a detecting antibody 
and is described elsewhere [25]. The annexin VIII specific ELISA is 
based on IA-Abv,,, and is described as follows: 96-well maxisorp plates 
(Nunc) were coated with IA-Abv,,, by incubating each well with lOO@ 
of 2.5 pg IA-Abv,,,/ml of NaHCOJNa,CO,, pH 9.0, during 2 h at 37°C. 
The coated wells were further blocked for aspecific protein binding sites 
with PBT (phosphate buffered saline, containing I mg/ml bovine serum 
albumin and 0.05% Tween 20 (w/v)). Samples were then added to the 
wells and incubated for 1.5 h at ambient emperature. The wells were 
washed free of unbound protein with PBT before the addition of bioti- 
nylated IA-Abv,,,, that was diluted in PBT. Incubation was continued 
for 1 h at ambient emperature. After washing with PBT, streptavidin- 
peroxidase (Amersham RPN 123 1; 1: 500 diluted in PBT) was added 
to each well and incubated uring 1 h at room temperature. The amount 
of bound peroxidase per well was assessed by staining with o-phenylene 
diamine, that was diluted to 2 mg/ml in 0.1 M sodium citrate, pH 5.0, 
containing 0.0025% H,Oz. The reaction was stopped with 4 N H2S04 
and optical density was measured at 492 nm. 
2.5. Annexin VIII quantitation in human tissues and cultured cells 
Human tissues were obtained after autopsy within 2 h postmortem. 
The tissues were solubilised to a 25% mixture (w/v) in ice-cold homo- 
genisation buffer (50 mM Tris-HCl, pH 7.9, 4 mM EDTA, 5 mM 
benzamidin and 5 PM soybean trypsin inhibitor) by ultrasonication. 
The mixture was then centrifuged for 5 min at 10,000 x g and the 
supernatant was assayed in the Annexin V and VIII ELISAs. 
Cultured human fibroblasts, human arterial smooth muscle cells, 
human umbilical vein endothelial cells and HeLa cells were lifted from 
the culture dish by mild trypsinisation and washed with PBS. The cells 
were finally suspended in homogenisation buffer at lo6 cells/ml and 
disrupted by ultrasonication. After centrifugation for 5 min at 
10,000 x g the supernatants were assayed in the Annexin V and VIII 
ELISAs. 
2.6. Immunohistochemistry 
Human tissue fragments were fixed in 4% neutral buffered formalin, 
processed and 4 ym paraffin sections were deparaffinized, rehydrated 
and treated with 0.6% H,O, in methanol to block endogenous peroxi- 
dase activity. Endogenic biotin and avidin binding were also blocked 
using a commercially available Avidinlbiotin blocking kit (Vector SP- 
2001). Diluted anti-Annexin VIII antibody was incubated with the 
tissue section in humidified air for 60 min at room temperature. After 
extensive washing with Tris-buffered saline at pH 7.5 (TBS), a diluted 
biotin labelled goat anti-rabbit IgG antibody (Dako, Denmark) was 
incubated for 60 min at room temperature. Subsequently after extensive 
washing with TBS diluted streptavidin-biotin-HRP solution (Dako, 
Denmark) was added and incubated for 30 min. Immunoreactivity was 
visualised by incubation with diaminobenzidine-H2 substrate. 
3. Results 
3.1. Annexin VIII spec@ic ELISA 
With an Annexin VIII specific polyclonal antiserum, 
that was used in unbiotinylated form as a catching anti- 
body and in biotinylated form as a detecting antibody, 
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an ELBA was constructed to quantify Annexin VIII in 
biological samples. The ELBA measured Annexin VIII 
in the range from 0.5-15 ng/ml (Fig. 1). Homology be- 
tween the primary structures of the different members of 
the Annexin family is high in specific domains and the 
presence of other Annexins in the samples could give 
therefore false positive signals in the Annexin VIII 
ELISA. Annexins I through VI were purified from 
human placenta and identified by their respective anti- 
bodies in Western blot procedures (data not shown). 
When assayed by the Annexin VIII ELISA, Annexins 
I-VI up to 1 @ml did not produce signals above the 
blank value. When 10 @ml of Annexin VIII was spiked 
into 1 &ml of another Annexin solution the added 
amount of Annexin VIII was fully recovered by the 
ELISA. 
3.2. Annexin V and VIII contents in human tissues 
The procedure to prepare samples of the human tis- 
sues for the ELISA involved ultrasonication in buffer. In 
order to exclude the possibility that this procedure would 
affect the response in the ELISA, reference curves were 
prepared with purified Annexins V and VIII, that had 
received the same treatments. It appeared that this way 
of sample handling had no effect on the response in the 
ELISAs. 
Table 1 lists the human tissues, that were investigated 
by the ELISAs, together with the measured contents of 
Annexins V and VIII. All tissues contained Annexin V, 
whereas Annexin VIII was detectable only in lung, skin, 
liver and kidney. When Annexin VIII was spiked into the 
tissue extracts to a level of 1 &ml this amount was fully 
recovered by the ELISA, which indicates once more the 
specificity of the Annexin VIII ELISA. 
In the positive tissues Annexin VIII levels were ap- 
proximately 70-100 times less than Annexin V levels. 
The Annexin VIII contents was the highest in lung tissue 
as was the Annexin VIII over Annexin V ratio of this 
1.5 
1 
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0 5 10 15 
Annexin VIII, nglml 
Fig. 1. Standard curve of recombinant Annexin VIII. The Annexin VIII 
specific ELISA was performed with purified recombinant Annexin VIII 
as described in section 2. 
C.PM Reutelingsperger et al. IFEBS Letters 349 (1994) 120-124 
Fig. 2. Immunohistochemical staining of a frozen section of human lung. A frozen section of human lung was incubated with anti-Annexin VIII 
antibodies. Specifically bound antibodies were visualised with anti-rabbit antibodies conjugated to horseradish peroxidase as described in section 2. 
tissue. Western blot analysis revealed that the lung tissue 
contained an anti-Annexin VIII positive band of 35 kDa, 
that comigrated with recombinant Annexin VIII (not 
shown). No other bands were visible. 
3.3. Immunohistochemical localisation of Annexin VIII in 
human lung tissue 
The human lung was further investigated for its ex- 
pression of Annexin VIII. Using immunohistochemical 
techniques on 4 ym sections of human lung it was shown 
that the endothelium of venous as well as arterial vessels 
stained with IA-Ab,,,, (Fig. 2). The other cell types ap- 
peared negative for IA-Ab,,,,. Staining of the lung endo- 
thelium was obliterated by preincubation of the primary 
antibody with purified Annexin VIII. 
3.4. Annexin VIII expression by cultured cells 
The expression of Annexin VIII appeared to be re- 
stricted to a few tissues and, within the lung tissue, to the 
endothelial cell. We investigated a number of cultured 
cell types by the ELISA procedures. In agreement with 
the tissue distribution profile Annexin V was expressed 
by all cell types investigated (Table 2). On the other 
hand, Annexin VIII was not detectable in smooth muscle 
cells and lung fibroblasts as expected but was also not 
detectable in HUVEC. This finding suggests that endo- 
thelial expression of Annexin VIII is determined by the 
tissue environment. HeLa cells, a human epitheloid car- 
cinoma cell line, express Annexin VIII at a level which 
is about 14 times lower than the Annexin V level. West- 
ern blot analysis with anti-Annexin VIII antibodies re- 
vealed a 35 kDa band, that comigrated with recombinant 
Annexin VIII (not shown). No other bands were visible. 
4. Discussion 
The genetic information of Annexin VIII, a four do- 
main structured member of the Annexin family, has been 
discovered in a human placenta cDNA library by a 
Table 1 
Annexin V and VIII contents in human tissues as measured by ELBA 
Tissue sample Annexin V” Annexin VIII” VIII/V 
Lung 16.1 
Skin 5.3 
Liver 19.3 
Kidney 18.2 
Heart 11.5 
Skeletal muscle 5.9 
Uterus 38.8 
Spleen 122 
0.23 0.014 
0.07 0.014 
0.17 0.009 
0.09 0.005 
N.D.” 
N.D. _ 
N.D. _ 
N.D. _ 
The numbers presented are the mean of duplo’s of two separate deter- 
minations. 
*Numbers are expressed in pg Annexin per g of wet tissue. 
b Not detectable. 
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screening procedure that employed a probe designed to 
pick up Annexin V cDNA [ 111. Prior to discovery of the 
native Annexin VIII protein its recombinant counterpart 
was expressed in Escherichia coli and investigated for 
several biological properties. These studies show that the 
Annexin VIII message ncodes a protein, that displays 
biological activities, which are typical for Annexins, e.g. 
the Ca2’-dependent phospholipid binding and the inhibi- 
tion of phospholipase A,- and prothrombinase activity. 
Whether these properties reflect the physiological func- 
tion of Annexin VIII has not yet been subject of investi- 
gations since the native Annexin VIII escaped detection 
in tissues until recently. 
Pepinsky and Hauptmann have detected Annexin VIII 
protein in placental tissue [20]. In contrast to the other 
members Annexin VIII mRNA [l l] and protein [20] are 
expressed at low levels in this tissue. Previously Tsao et 
al. reported a partial sequence of a rabbit lung protein 
(33000 PBLP), which shares 88% homology with the first 
repeat of Annexin VIII [27]. On basis of the observed 
high interspecies conservation of several Annexins [7] 
this would indicate that 33000 PBLP is the rabbit homo- 
logue of human Annexin VIII. However, the presented 
purification data [28] allow the estimation that one New 
Zealand rabbit lung contains at the least 0.5 mg of 33000 
PBLP, a level which is beyond that of Annexin VIII in 
placenta [20] and human lung (this report). Hence, in 
spite of the high sequence similarity the 33000 PBLP is 
probably distinct from Annexin VIII. 
This paper reports the expression of Annexin VIII 
protein in various human tissues and compares this with 
the expression of Annexin V, which is known to occur 
widely spread and abundantly in the organism [29]. To 
this end an Annexin VIII specific ELISA was con- 
structed with rabbit polyclonal antibodies raised against 
the recombinant Annexin VIII. With the ELISA tech- 
nique it is shown that Annexin VIII expression is limited 
both in the sense of tissue distribution and concentration 
per tissue. In these respects Annexin VIII is discerned 
from most other members, which are widely spread and 
abundantly expressed in the organism. In comparison to 
Annexin V, Annexin VIII is expressed at levels, which 
are around two orders of magnitude lower. The abun- 
Table 2 
Annexin V and VIII contents in cultured cells as measured bv ELISA 
Tissue sample Annexin V” Annexin VIII” VIII/V 
HUVEC 2.08 N.D.b _b 
Smooth muscle cell 2.24 N.D. _ 
Fibroblast 4.44 N.D. _ 
Hela cell 0.94 0.069 0.073 
The numbers presented are the mean of duplo’s of three separate deter- 
minations. 
“Numbers are expressed in pg Annexin per mg of total cellular protein. 
bNot detectable. 
dant and ubiquitous presence of the first suggests its 
participation in the cellular basic machinery. Along this 
line of reasoning Annexin VIII would be a candidate for 
a highly specialised function accomodating tissue and 
cell-type specific requirements. This notion is strength- 
ened by the fact that Annexin VIII is not expressed by 
every cell-type and for a given cell-type not in every 
tissue. The endothelial cells of the lung contain Annexin 
VIII, whereas it appears to be absent in other cell-types 
of the lung. Moreover, Annexin VIII appears not to be 
a common property of the endothelial cell since endothe- 
lial rich tissues like heart and spleen, and cultured 
HUVEC lack this protein [this report,30]. Tissue and 
cell-type specific expression has been recognised in verte- 
brates [31] and in lower organisms [32] for some other 
members of the Annexin family. The physiological roles 
of these Annexins are also not yet defined but are sought 
in the region of highly specialised functions. 
No biological activities of the native Annexin VIII 
have been reported so far. The recombinant product 
exhibits Ca2’-dependent phospholipid binding and based 
hereon anti-phospholipase A, and prothrombinase in- 
hibitory activity and phospholipid vesicle aggregating 
capacity (CPMR; unpublished results). These activities 
are also expressed by other Annexins and have led to 
postulation of physiological roles in the areas of inflam- 
mation [33], haemostasis [34,35] and exocytosis [36]. 
Activation of the Annexin VIII gene has recently been 
reported for a primary leukemic cell [21] and several 
leukemic and lymphoid cell lines [22]. Coagulopathien 
are mostly observed in patients suffering from acute pro- 
myelocytic leukemia type M3. As these myeloid cells 
express Annexin VIII gene transcripts it has been sug- 
gested that the Annexin VIII protein is directly associ- 
ated with the bleeding disorder of these patients. These 
myeloid cells shut-down the Annexin VIII gene when 
they are directed towards maturation by agents like all 
trans retinoic acid and phorbol ester [21,22]. This sug- 
gests that Annexin VIII is linked to the machineries that 
determine proliferation and differentiation. Whether An- 
nexin VIII in these cells is a marker of proliferation and 
differentiation or a factor driving or regulating one of 
these processes is unknown. HeLa cells with epithelial 
like morphology, that proliferate continuously, and the 
lung endothelial cells, which likely have a very low prolif- 
erative index, both express Annexin VIII. Hence, An- 
nexin VIII expression may occur in differentiated as well 
as undifferentiated cells and in proliferating as well as 
non-proliferating cells. The direction in which the search 
for the function(s) of Annexin VIII should be pursued is 
not yet clear. Elucidation of the biochemical characteris- 
tics and the subcellular localisation of the native protein 
would mean a step further. 
In conclusion, Annexin VIII displays a unique tissue 
and cellular distribution in human. When expressed it 
occurs at relatively low levels. All together these data 
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indicate a highly specialised function(s) accomodating 
specific tissue and cell-type dependent requirements. 
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